R&D Software Engineering Lead (Regulated Health Tech)
Inofab Sağlık Teknolojileri Anonim Şirketi
Obtenez une réponse de cet employeur
Votre CV et votre lettre de motivation, adaptés exactement à ce que l’employeur recherche.
Avantages offerts par ce poste
Résumé du poste
Inofab Sağlık Teknolojileri Anonim Şirketi is seeking an Associate Director, R&D Software Engineering to lead end-to-end software development efforts in compliance with regulatory standards. You will oversee architecture, development, testing, and release management while managing multiple teams in a healthcare context.
The ideal candidate will possess a Bachelor's degree in Computer Science or Engineering and have over 10 years of experience in software development within the medical device industry, exemplifying strong leadership and technical skills.
Join us to transform lives and bring life-changing therapies to patients faster.
Qualifications
- 10+ years of experience in software development in the medical device industry.
- Proven experience leading software teams delivering regulated products.
- Strong understanding of Agile development practices in regulated environments.
Responsabilités
- Define and execute technical and management strategy for software products.
- Partner with Product Management to translate requirements into plans.
- Monitor progress against plans and report variances.
Connaissances
Formation
Description du poste
Inofab Sağlık Teknolojileri Anonim Şirketi is seeking an Associate Director, R&D Software Engineering to lead end-to-end software development efforts in compliance with regulatory standards. You will oversee architecture, development, testing, and release management while managing multiple teams in a healthcare context.
The ideal candidate will possess a Bachelor's degree in Computer Science or Engineering and have over 10 years of experience in software development within the medical device industry, exemplifying strong leadership and technical skills.
Join us to transform lives and bring life-changing therapies to patients faster.
'/%3e%3cpath%20d='M101.744%2012.4726L102.894%2016.1947L99.0021%2013.2201L101.744%2012.4726ZM105.3%208.40937H100.488L99.0026%203.59473L97.5116%208.41047L92.7%208.40385L96.5965%2011.3834L95.1055%2016.1942L99.0021%2013.2196L101.408%2011.3834L105.3%208.40992V8.40937Z'%20fill='white'/%3e%3cdefs%3e%3clinearGradient%20id='paint0_linear_5593_1381'%20x1='90'%20y1='9.44471'%20x2='99'%20y2='9.44471'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20stop-color='%2300AD70'/%3e%3cstop%20offset='0.998594'%20stop-color='%2300B67A'/%3e%3cstop%20offset='1'%20stop-color='%23DCDCE6'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e){kind=small}
